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Cutaneous lymphomas derived from natural killer (NK) or NK-like T-cells are rare among hematolymphoid malignancies presenting in the skin. [1] [2] [3] [4] [5] [6] We have recently reported a series of 12 patients with cutaneous presentation of NK and NK-like T-cell lymphomas that demonstrate a dense superficial and deep dermal lymphoid infiltrate often with an angiocentric growth pattern and a characteristic immunophenotype (CD56π, CD43π, TCRgª, CD3ª/π, CD20ª, CD4ª, CD8ª). 7 These lymphomas showed aggressive behavior with a median survival of 15 months from the time of diagnosis. In addition, one of the 12 cases displayed immunoreactivity of the CD56π atypical large cells for CD30, a member of the nerve growth factor receptor superfamily expressed in activated T and B cells, Hodgkin's disease and anaplastic large cell lymphoma. [8] [9] [10] [11] Cutaneous lymphoproliferative disorders expressing the CD30 antigen form a heterogeneous spectrum which encompasses lymphomatoid papulosis (LyP), some examples of tumor stage mycosis fungoides and several lymphomas with and without anaplastic cytology. [11] [12] [13] [14] [15] [16] [17] [18] Secondary cutaneous anaplastic large cell lymphoma (ALCL) and ALCL arising in mycosis fungoides have a poor prognosis, but primary cutaneous CD30π ALCLs are associated with a good prognosis with an overall survival rate estimated to be greater than 90% at 5 years. [13] [14] [15] [16] [17] [18] [19] NK and NK-like T-cell lymphomas involving the skin usually have a poor prognosis. While the biologic behavior of NK and NK-like T-cell lymphomas presenting in the skin and ALCLs are widely disparate, the initial clinical presentation as well as the histologic features can display significant overlap and may pose considerable diagnostic difficulty. Cutaneous lymphomas that coexpress CD56 and CD30 appear to be rare. 4, 6, [20] [21] [22] [23] [24] [25] The biological significance of this co-expression is as yet unclear.
We undertook the current study to characterize the clinical, morphologic, immunophenotypic and molecular features of lymphomas presenting in the skin that co-express CD56 and CD30. In addition, we have tested for the presence of the Epstein-Barr virus 
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(EBV), which is variably associated with both ALCL and NK and NK-like T-cell malignancies. 3, 4, 6, 7, 20, 26 Material and methods Case selection A review of Stanford surgical pathology records from 1995-1998 yielded 52 cases of cutaneous lymphoproliferative disorders with reactivity for CD30.
Immunostains for CD56 were performed on these cases as described below. All cases of NK and NKlike T-cell lymphomas had been previously tested for CD30. 7 In addition, 10 cases of ALCL seen at the University of Michigan (Ann Arbor, MI, USA) were also stained for CD56. From these cases, seven lymphomas that co-express CD56 and CD30 with presentation of disease in the skin were selected. Histologic sections and immunohistochemical studies performed at the time of diagnosis were reviewed. The staging evaluation at the time of diagnosis included complete blood count and chemistries, chest X-ray or chest computed tomography (CT), CT of abdomen and pelvis, and bone marrow biopsy.
Histologic features
Hematoxylin and eosin (H&E)-stained sections were reviewed to assess histologic parameters including epidermotropism, angiocentrism, angiodestruction, fat involvement, ulceration, necrosis, anaplasia, prominence of nucleoli, and karyorrhexis. These parameters were categorized as absent/inconspicuous (ª), mild (π), or prominent (ππ).
Immunohistochemistry
Primary antibodies were directed against CD3, CD4, CD8, CD20, CD30, CD43, CD56, CD68, TIA1, MPO (myeloperoxidase) and Ki-67 (summarized in Table 1 ). Serial sections of 4 microns were cut and deparaffinized in xylene and hydrated in a graded series of alcohol. The sections were then pretreated by a microwave procedure in citric acid buffer (10 mM, pH 6.0) for 10 min prior to staining for CD3, CD8, CD20, CD30, CD43, CD56, CD68, TIA-1, and Ki-67. For CD4, pretreatment was performed in EDTA (1mM, pH 8.0). Endogenous peroxidase was blocked by preincubation with 1% hydrogen peroxide in phosphate-buffered saline. Detection for CD3, CD20, CD30, CD43, CD68, MPO and TIA-1 was performed on an automated staining machine (Ventana Medical Systems Inc., Tucson, AZ, USA). Detection for CD56, Ki-67, and CD4 was performed using a modified biotinstreptavidin method. 27 In situ hybridization for EBV EBV RNA in situ hybridization studies were performed using a 30-base oligonucleotide probe complementary to a portion of the EBER1 gene as previously described. 28 Five-micron thick paraffin sections were deparaffinized, rehydrated, predigested with proteinase K and hybridized overnight at a concentration of 0.25 ng/ml of biotinylated probe. Detection was accomplished using avidin-alkaline phosphatase conjugate. Appropriate positive and negative controls were performed.
Heteroduplex analysis of T-cell receptor gamma (TCR-g) gene rearrangement
Amplification and heteroduplex analysis for TCR-g gene rearrangement was performed as previously described. 29 Consensus primers for the TCR V-J junction were used to amplify genomic DNA isolated from paraffin-embedded tissue as described. 29 The amplified products were then analyzed on a Mutation Detection Enhancement (MDE) gel (FMC Bioproducts, Rocklands, ME, USA) for 12 h at 90 V in tris-borate-EDTA buffer. 
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Results
Clinical features
The clinical findings are summarized in Table 2 . The patients included four men and three women ranging in age from 19 to 79 years (mean age 46.7 years). All patients presented with initial manifestation of lymphoma in the skin. Six patients had disease confined to the skin as assessed by a staging workup. One patient (case 6) developed involvement of the soft palate 6 months after the initial skin diagnosis. None of the patients had lymph node or peripheral blood involvement. Four of the seven patients had multiple skin lesions at presentation, while three had disease limited to a single cutaneous lesion. The initial cutaneous lesions were found on the upper and/or lower extremities in four patients, confined to the hip in one patient and involved the trunk in addition to the extremities in the remaining two patients. None of the patients had significant past medical histories, evidence of immunosuppression or prior malignancies.
The disease course was variable in the seven patients (Table 2) . Four patients are in clinical remission without relapse (cases 1, 2, 3, and 5), one patient is in remission with history of relapse (case 4), one patient is alive with recurrent disease (case 7), and one patient died of disease (case 6). Three patients were initially treated with chemotherapy (case 1, 2 and 4) of whom two, in addition, received local (case 1) or total skin radiation (case 2). Patient 2 received an autologous bone marrow transplantation after only partial response to initial therapy, and is in clinical remission at the time of completion of this study. Two patients were treated initially with local radiation alone (cases 3 and 6), one of whom remains in clinical remission (case 3), while the other patient had recurrence involving the trunk, extremities and the soft pal- 
All histologic parameters were scored as follows: Absent/inconspicuous (ª), mild (π), prominent (ππ), or not assessed (NA). * no epidermis available for assessment of epidermotropism. ** depth of biopsy insufficient for evaluation of panniculitis-like infiltrate.
ate requiring chemotherapy and died of disease (case 6). Two patients received no treatment at all (cases 5 and 7). Patient 5 who presented with a single nodule on the toe, underwent spontaneous resolution and is without disease two years after diagnosis. The other patient continues to have recurrent self-resolving nodules (case 7).
Histologic features
The histologic findings are summarized in Table 3 . The skin biopsies from all seven patients exhibited dense lymphoid infiltrates with atypical cytologic features. These infiltrates had a ''column-like'' architecture exemplified by extension of the infiltrates from the superficial to the deep dermis with prominent perivascular and periappendageal involvement. An increased density of neoplastic cells was present deep within the dermis (Fig. 1A) . Epidermotropism was a minor component in four of six cases, although in one case a prominent epidermal infiltrate was seen (case 5). Angiocentric infiltrates were observed in all cases, while angiodestructive lesions were present in five cases (Fig. 1B) . Destruction of adnexal structures was not observed. Involvement of the fat (panniculitis-like infiltration) was a prominent finding in four of five cases where the depth of the biopsy was adequate for assessment of this parameter. Ulceration was present in three cases (2, 4 and 6), while areas of necrosis within the dermis were observed in two biopsies (cases 3 and 6).
The cytology of the lymphoid infiltrates revealed a mixture of cell sizes ranging from small to medium to large. In all biopsies, the medium-to large-sized cells displayed nuclear pleomorphism; however, anaplastic cytology was prominent in three cases (1, 4, and 6; Fig. 1C ). Marked karyorrhexis was present in five of seven cases. Scattered small lymphoid cells and histiocytes were admixed with the large atypical cells, most likely representing a host response. Occasional histiocytes and eosinophils were also present intermingled with the atypical lymphoid cells.
Immunohistochemical studies
Results from immunohistochemical studies are summarized in Table 4 . Cutaneous biopsies from all seven patients revealed immunoreactivity of the large atypical cells for CD56 and CD30 ( Fig. 2A, B) , as this was a criterion for selection for the study. Staining for both markers was predominantly localized to the cell membranes. The number of atypical cells stained in each case was variable, as indicated in Table 4 . Six of the seven cases displayed immunoreactivity with polyclonal anti-CD3, which recognizes the epsilon (e) subunit of the T-cell receptor-CD3 signal transduction complex (Fig. 2C) . All cases showed strong immunoreactivity for CD43. The atypical cells from all seven cases lacked staining for the T-helper/inducer marker, CD4, T-cytotoxic/suppresser marker, CD8, the B-cell marker CD20, myeloperoxidase (MPO) and the myeloid/macrophage-associated antigen, CD68. A subset of small lymphoid cells showed positive staining for CD8 (Fig. 2D ). These cells presumably correspond to reactive T cells. Three of seven cases showed staining for TIA-1 (Fig. 2E ). All seven cases showed moderate to high proliferation rates (30-90%) as assessed by Ki-67, a nuclear antigen expressed in proliferating cells (Fig. 2F) , corroborating the histologic findings of often brisk mitotic activity seen on hematoxylin and eosin (H&E)-stained sections.
In situ hybridization for EBV Results of in situ hybridization studies are summarized in Table 4 . Using the EBER1 oligonucleotide probe, three of seven cases exhibited nuclear localization of EBV mRNA within atypical cells constituting the cutaneous lymphoid infiltrates. 
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Heteroduplex analyses of TCR-g gene rearrangement
Results of TCR-g rearrangement studies are summarized in Table 4 . Three cases showed strong clonal bands indicating the presence of TCR-g gene rearrangements. As T-cell receptor gene rearrangements would not be expected in lymphomas derived from natural killer cells, these three lymphomas are most likely derived from T cells.
Discussion
The seven patients described in this study are unusual in that they had lymphomas exhibiting a rare CD56π, CD30π immunophenotype with the initial manifestation of their disease in the skin. There are a few reports of lymphomas with co-expression of CD56 and CD30. 4, 6, 7, 20, 21, [23] [24] [25] All of these reported cases of lymphomas were localized to extranodal sites, of which three presented with lymphoma in the skin. 7, 25 These investigations suggest that co-expression of CD56 and CD30, especially in lymphomas with primary presentation in the skin, is exceedingly rare.
The patients in the current study showed a wide age distribution and no particular sex predilection. The most common sites of involvement were the extremities and trunk, similar to previous reports of cutaneous NK and NK-like T-cell lymphomas, 3, 4, 7 and ALCL, although ALCL also commonly involves the scalp and face. 13, 17 Similarly, single or multiple nodules, often ulcerated were typical in these patients, as reported in both diseases. 3, 4, 7, 13, 17 Nuclear pleomorphism has been described in both NK and NKlike T-cell lymphomas and ALCL; however, prominent anaplastic cytology, a feature of three of the cases in this study, is particularly distinctive of ALCL. [1] [2] [3] 6, 7, 11, 13, 17, 30 While two of the patients in our study who displayed anaplastic cytology (cases 4 and 6) exhibited an aggressive clinical course, another patient whose biopsy displayed marked anaplasia (case 1), did not. Angiocentric distribution of the atypical infiltrate, present in all cases in this study, is commonly associated with NK and NK-like T-cell lymphomas ALCL. [1] [2] [3] 6, 7, 30 This pattern of infiltration is less frequent in ALCL. 17 Infiltration and destruction of vessel walls, apparent in five of seven cases in this study is most frequent in NK and NK-like T-cell lymphomas. [1] [2] [3] 6, 7, 30 Thus, the histologic features of these seven cases show significant overlap with those of NK and NK-like T-cell lymphomas and ALCL.
By definition, all seven cases in our study showed immunoreactivity for CD56 and CD30 in the large atypical cells, although variable numbers of cells exhibited positive staining for each of these markers. The typical immunophenotype was as follows: CD56π, CD30π, CD43π, CD3(e)π/ª, TIA1ª/ π, CD4ª, CD8ª, CD20ª, CD68ª, MPOª. Immunoreactivity for TIA-1, a cytoplasmic granule-associated protein found in cytotoxic T cells and NK cells, was observed in three of seven cases (42%) in our study. Other investigators have reported TIA-1 expression in 63-92% of ALCL and NK and NK-like T-cell lymphomas. 17, 25, [31] [32] [33] This immunophenotype shows significant overlap between the immunophenotypic profiles reported for NK and NK-like T-cell lymphomas and ALCL.
A very high correlation between NK and NK-like T-cell lymphomas, especially of the nasal-type, and EBV has been reported by some authors, 3, 5, 26, 34 while an inconsistent association has been reported by others. 7, 26 Occasional cases of ALCL are also known to harbor EBV mRNA, [35] [36] [37] [38] although a vast majority of ALCL cases lack EBV. 17 In the current study, EBV mRNA was detected in three of seven cases (42%), utilizing in situ hybridization studies for EBER1 mRNA. There was no distinct correlation between EBV mRNA expression and adverse clinical outcome in our study.
Immunoreactivity for cytoplasmic CD3 (CD3 epsilon), a component of the TCR signal transduction complex, was detected in six cases, while clonal TCRg rearrangement confirming a T-cell lineage was detected in only three cases. Thus, four of the cases in this study may be of true NK-cell derivation, as clonal rearrangement of TCR-g is a feature of T-cell lineage while CD3e can be expressed by cells of pure NK lineage. Immunohistochemical and molecular analyses have demonstrated clonality in approximately 91% of CD30π ALCL. 17, 32, 33 Thus, a minority of cases of ALCL may not exhibit detectable TCR gene rearrangements. The absence of TCR-g rearrangements in four cases in our study does not differentiate between a T-cell or an NK-cell derivation for these lymphomas. A bipotential progenitor cell giving rise to true NK lymphomas as well as NK-like T-cell lymphomas, [39] [40] [41] may be a likely derivation for lym-phomas co-expressing CD56 and CD30, especially for those with an adverse clinical course. However, an activated CD30π T-cell with aberrant expression of CD56, 21 may also be responsible for lymphomagenesis. While determining the cell of origin may be important for understanding the biological behavior of these lymphomas and for classification, it is not clear whether this is pertinent for diagnosis or management.
Cutaneous CD56π NK and NK-like T-cell lymphomas are highly aggressive and are often accompanied by treatment failure, multiple recurrences, dissemination to other sites and poor clinical outcome. [1] [2] [3] [4] 6, 7, 30 In contrast, CD30πALCLs that are limited to the skin at presentation as solitary or multiple nodules are associated with an excellent prognosis. Spontaneous regression with or without relapse is observed in CD30π ALCLs and the five year overall survival rate is estimated to be 90%. 11, [14] [15] [16] [17] [18] [19] The disease course of patients in our study was variable, and ranged from spontaneous resolution in one patient, clinical remission post-treatment in four patients, alive with recurrent disease in one patient, and death from disease with involvement of another extranodal site (soft palate) in one patient. While one of the patients (cases 6) had disease that behaved in a more aggressive manner than primary cutaneous CD30π ALCL, the other six patients displayed a clinical course considered typical for primary cutaneous CD30π ALCL. It is unclear whether the less aggressive clinical course in these latter six patients is due to the biological behavior associated with coexpression of CD56 and CD30 or to the limited involvement of their disease mostly in one anatomical location, or both. The rarity of primary cutaneous lymphomas with co-expression of CD56 and CD30, together with the relatively short follow-up period of patients in our study, make assessment of prognosis difficult. Further clinicopathologic investigations on larger numbers of patients are needed for an accurate and meaningful evaluation of prognosis in these lymphomas.
Our results indicate that cutaneous lymphomas that co-express CD56 and CD30 share significant clinicopathologic overlap with cutaneous ALCL and NK and NK-like T-cell lymphomas. Immunophenotypic studies are imperative in distinguishing these lymphomas from mycosis fungoides, lymphomatoid papulosis, peripheral T-cell lymphoma, subcutaneous panniculitic T-cell lymphoma, 42 myeloid/natural killer cell precursor lymphoma/leukemia, [43] [44] [45] CD4π CD56π cutaneous neoplasm, 46 and cutaneous B-cell lymphoma, which are considerations in the histologic differential diagnosis. Thus, CD56 and CD30 are important markers in a panel selected for immunohistologic studies when evaluating a dense deep dermal atypical lymphoid infiltrate, and both antigens should be assessed together. Predictions of prognosis based on our data are difficult. Further investigations are needed to characterize the mechanism of how a neural cell adhesion molecule such as CD56 and a growth factor receptor-like molecule such as CD30 may orchestrate the pathogenesis and progression of these rare lymphomas.
